Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Caraco Pharmaceutical Labortories Ltd. (CPD)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: CPD
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Comments on CPD
Mylan: Generic Drugmaker with a Strong Portfolio
[View article]
BPI: No regrets. Your comment was fair and reasonable here. With regard to the fellow who tried to get hit by the bus, he's a...
More »
Comment by
Justin M. Hall
Sep 14 05:01 am
|
Rating:
+1
0
Mylan: Generic Drugmaker with a Strong Portfolio
[View article]
Peter: You're welcome! I share your sentiment on MYL - it should continue its climb from here! Thanks for the...
More »
Comment by
Justin M. Hall
Sep 14 04:49 am
|
Rating:
+1
0
Mylan: Generic Drugmaker with a Strong Portfolio
[View article]
I shouldn't have put that comment in. I apologize. Just a little sentiment on the pay scale I received for working in a rural area out...
More »
Comment by
BioPharma Investor
Sep 13 04:14 am
|
Rating:
+2
0
Mylan: Generic Drugmaker with a Strong Portfolio
[View article]
Thanks, Justin! I held MYL for two-three years by now. I then bought more MYL shares after earnings call, not because of BPI's...
More »
Comment by
peter Hsu
Sep 13 03:05 am
|
Rating:
+1
0
Mylan: Generic Drugmaker with a Strong Portfolio
[View article]
Peter: While you may be uncomfortable with it, he's right. King Pharma (KG) has positioned itself near Appalachia and is doing quite...
More »
Comment by
Justin M. Hall
Sep 12 09:00 am
|
Rating:
+2
0
Contrarian Stock Screen: Biggest Losers in 2009
[View article]
how can we see this ? print way too small
Comment by
buyforeclosures
Sep 2 11:18 am
|
Rating:
0
0
Mylan: Generic Drugmaker with a Strong Portfolio
[View article]
I felt uncomfortable with the writer's coments on: "But to run a business in a lower economic area like West Virginia can be...
More »
Comment by
peter Hsu
Aug 29 03:02 am
|
Rating:
0
-2
Mylan: Generic Drugmaker with a Strong Portfolio
[View article]
Lies Lies its all lies....I love a little controversy. Look, the PR Newswires alone should help you in your decision on Mylan. ...
More »
Comment by
BioPharma Investor
Aug 28 14:17 pm
|
Rating:
+1
0
Mylan: Generic Drugmaker with a Strong Portfolio
[View article]
So I add my own input to an article to make it a little more than just a business article. If you don't like the article don't read it....
More »
Comment by
BioPharma Investor
Aug 28 13:13 pm
|
Rating:
+1
0
Caraco Pharmaceutical: Underappreciated and Undervalued, Part 2
[View article]
The generic drug sector is very promising. This article and its thoroughness is very helpful. Thank you Pakiya
Comment by
Marc Courtenay
Aug 14 13:55 pm
|
Rating:
0
0
Caraco Pharmaceutical: Underappreciated and Undervalued, Part 2
[View article]
the margin of safety is the assets the company owns. CPD has about 50M in cash, 60M in PP&E, and owns over IP for over 25 generic...
More »
Comment by
Pakiya
Aug 13 15:42 pm
|
Rating:
+1
0
Caraco Pharmaceutical: Underappreciated and Undervalued, Part 2
[View article]
One thing we could analyze on the FDA raid is the margin of safety if these issues are not solved. - Will the licensing cash flow...
More »
Comment by
PlanMaestro
Aug 13 09:41 am
|
Rating:
0
0
Caraco Pharmaceutical: Underappreciated and Undervalued, Part 2
[View article]
In addition to all of the analysis thank you for such a thorough & informative read.
Comment by
CBrown
Aug 13 02:20 am
|
Rating:
0
0
Caraco Pharmaceutical: Underappreciated and Undervalued, Part 2
[View article]
there isn't much to say about the FDA raid. the company can't manufacture any drugs until it fixes the FDA issues. i think it will be...
More »
Comment by
Pakiya
Aug 13 00:37 am
|
Rating:
0
0
Caraco Pharmaceutical: Underappreciated and Undervalued, Part 2
[View article]
If SUNP decides to buyout Caraco, it will have to pay a premium to the current price. Caraco makes 20-25M in cash each year. At current...
More »
Comment by
Pakiya
Aug 13 00:28 am
|
Rating:
0
0
1
2
3
4
5
6
Next Page
Mylan: Generic Drugmaker with a Strong Portfolio [View article]
Mylan: Generic Drugmaker with a Strong Portfolio [View article]
Mylan: Generic Drugmaker with a Strong Portfolio [View article]
Mylan: Generic Drugmaker with a Strong Portfolio [View article]
Mylan: Generic Drugmaker with a Strong Portfolio [View article]
Contrarian Stock Screen: Biggest Losers in 2009 [View article]
Mylan: Generic Drugmaker with a Strong Portfolio [View article]
Mylan: Generic Drugmaker with a Strong Portfolio [View article]
Mylan: Generic Drugmaker with a Strong Portfolio [View article]
Caraco Pharmaceutical: Underappreciated and Undervalued, Part 2 [View article]
Caraco Pharmaceutical: Underappreciated and Undervalued, Part 2 [View article]
Caraco Pharmaceutical: Underappreciated and Undervalued, Part 2 [View article]
Caraco Pharmaceutical: Underappreciated and Undervalued, Part 2 [View article]
Caraco Pharmaceutical: Underappreciated and Undervalued, Part 2 [View article]
Caraco Pharmaceutical: Underappreciated and Undervalued, Part 2 [View article]